NCT07730515
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Clinical trial condition
Peripheral T-cell Lymphoma
Explore clinical trials studying Peripheral T-cell Lymphoma. Study availability and eligibility vary by location and protocol.
100 public trials
16 recruiting studies
Peripheral T-cell Lymphoma trial results
Recruiting
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
NCT06176690
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type, +17 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
- Texas Children's Hospital Houston, Texas, United States
- Conditions
- Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Cutaneous T-Cell Lymphoma, +23 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Recruiting
A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19)
NCT07234162
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Anhui Provincial Cancer Hospital Hefei, Anhui, China
- The Second Hospital of Anhui Medical University Hefei, Anhui, China
- Beijing Hospital Beijing, Beijing Municipality, China
- Beijing Tongren Hospital, CMU Beijing, Beijing Municipality, China
NCT07523555
- Conditions
- BPDCN; Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, +50 more
- Locations
-
- Peking University Shenzhen Hospital Shenzhen, Guangdong, China
NCT04512534
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Dongmei Ji Shanghai, Shanghai Municipality, China
NCT07270861
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Recruiting
Amping up With PemJAK
NCT07283822
- Conditions
- Cutaneous T-Cell Lymphomas, Gray Zone Lymphoma, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Columbia University Irving Medical Center New York, United States
NCT06421948
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, Henan, China
- Liling Zhang Wuhan, Hubei, China
- Yajun Li Changsha, Hunan, China
- Ming Jiang Chengdu, Sichuan, China
Recruiting
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
NCT04234048
- Conditions
- Angioimmunoblastic T-cell Lymphoma, Cutaneous T-Cell Lymphoma, Cutaneous T-Cell Lymphoma, Unspecified, +23 more
- Locations
-
- Mayo Clinic Arizona Scottsdale, Arizona, United States
- City of Hope Medical Foundation Duarte, California, United States
- University of Southern California Los Angeles, California, United States
- University of Colorado Anschutz Medical Campus Aurora, Colorado, United States